NAMBU; Mitchell David

Patent Applications and Registrations

Patent applications and USPTO patent grants for NAMBU; Mitchell David.The latest application filed is for "enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors".

Company Profile

0.13.18

NAMBU; Mitchell David - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors App 20140288086 - CUI; Jingrong Jean ; et al.	2014-09-25
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors Grant 8,785,632 - Cui , et al. July 22, 2	2014-07-22
4-methylpyridopyrimidinone compounds Grant 8,633,204 - Cheng , et al. January 21, 2	2014-01-21
4-methylpyridopyrimidinone Compounds App 20120309775 - CHENG; Hengmiao ; et al.	2012-12-06
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors App 20120263706 - Cui; Jingrong Jean ; et al.	2012-10-18
4-methylpyridopyrimidinone compounds Grant 8,273,755 - Cheng , et al. September 25, 2	2012-09-25
Aminoheteroaryl compounds as protein kinase inhibitors Grant 8,106,197 - Cui , et al. January 31, 2	2012-01-31
Therapeutic compounds Grant 7,868,026 - Nambu , et al. January 11, 2	2011-01-11
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors Grant 7,858,643 - Cui , et al. December 28, 2	2010-12-28
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors App 20100324061 - Cui; Jingrong Jean ; et al.	2010-12-23
Triazolopyrazine derivatives Grant 7,732,604 - Cheng , et al. June 8, 2	2010-06-08
4-methylpyridopyrimidinone Compounds App 20100137279 - Cheng; Hengmiao ; et al.	2010-06-03
Triazolopyrazine Derivatives App 20100105656 - Cheng; Hengmiao ; et al.	2010-04-29
4-methylpyridopyrimidinone compounds Grant 7,696,213 - Cheng , et al. April 13, 2	2010-04-13
4-methylpyridopyrimidinone Compounds App 20080090801 - Cheng; Hengmiao ; et al.	2008-04-17
Triazolopyrazine Derivatives App 20070265272 - Cheng; Hengmiao ; et al.	2007-11-15
Therapeutic Compounds App 20070167497 - Nambu; Mitchell David ; et al.	2007-07-19
Aminoheteroaryl compounds as protein kinase inhibitors Grant 7,230,098 - Cui , et al. June 12, 2	2007-06-12
Aminoheteroaryl compounds as protein kinase inhibitors App 20070072874 - Cui; Jingrong Jean ; et al.	2007-03-29
Aminoheteroaryl compounds as protein kinase inhibitors App 20060178374 - Cui; Jingrong Jean ; et al.	2006-08-10
Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors App 20060128724 - Cui; Jingrong Jean ; et al.	2006-06-15
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors App 20060046991 - Cui; Jingrong Jean ; et al.	2006-03-02
Aminoheteroaryl compounds as protein kinase inhibitors App 20050009840 - Cui, Jingrong Jean ; et al.	2005-01-13
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use App 20040092747 - Bender, Steven Lee ; et al.	2004-05-13
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use Grant 6,635,641 - Bender , et al. October 21, 2	2003-10-21
Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use Grant 6,620,828 - Chu , et al. September 16, 2	2003-09-16
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use App 20020103203 - Bender, Steven Lee ; et al.	2002-08-01
Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use App 20020025976 - Chu, Shao Song ; et al.	2002-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.